HERON THERAPEUTICS, INC. /DE/

HRTX · Nasdaq · SIC 2834: Pharmaceutical Preparations
360
SEC Filings

Business Summary

. Overview We are a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients. Acute Care Product Portfolio ZYNRELEF ZYNRELEF is a dual-acting...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionHRTXdiscussed_in_filing Cybersecurity
topic_mentionHRTXdiscussed_in_filing Cybersecurity
topic_mentionHRTXdiscussed_in_filing Healthcare & Bio
topic_mentionHRTXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073515EDGAR69K words
2025-02-272024-12-310000950170-25-028374EDGAR—
2024-03-122023-12-310000950170-24-029951EDGAR—
2023-03-292022-12-310000950170-23-010603EDGAR—
2022-02-282021-12-310001564590-22-007618EDGAR—
2021-02-242020-12-310001564590-21-007841EDGAR—
2020-03-022019-12-310001564590-20-007973EDGAR—
2019-02-222018-12-310001193125-19-047780EDGAR—
2018-02-272017-12-310001193125-18-060951EDGAR—
2017-02-232016-12-310001193125-17-054088EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-263618EDGAR26K words
2025-08-082025-06-300000950170-25-105475EDGAR—
2025-05-062025-03-310000950170-25-063971EDGAR—
2024-11-122024-09-300000950170-24-124698EDGAR—
2024-08-062024-06-300000950170-24-091764EDGAR—
2024-05-072024-03-310000950170-24-053964EDGAR—
2023-11-142023-09-300000950170-23-063714EDGAR—
2023-08-142023-06-300000950170-23-042431EDGAR—
2023-05-112023-03-310000950170-23-021237EDGAR—
2022-11-082022-09-300001564590-22-037047EDGAR—
2022-08-092022-06-300001564590-22-028599EDGAR—
2022-05-092022-03-310001564590-22-018877EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001193125-26-142947EDGAR9K words
2026-02-260001193125-26-073502EDGAR—
2026-01-090001193125-26-008631EDGAR—
2025-11-040001193125-25-263617EDGAR—
2025-10-290001193125-25-256300EDGAR—
2025-10-150001193125-25-240253EDGAR—
2025-08-280000950170-25-112048EDGAR—
2025-08-150000950170-25-109234EDGAR—
2025-08-120000950170-25-107416EDGAR—
2025-08-120000950170-25-107404EDGAR—

360 total filings indexed. 328 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000818033
TickerHRTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b2c0e64e7920e319078f7ebd1d3c780130294d28368cc79347203087c3410208
parent: 22901c41319a31c0ba9b5daecf63170504c1af264cb34b3db0a08525a1326aa3
content hash: e811affe40efd1d64ce0fe180d31d44d535bef182d0b0c799e47ffef9357dff7
signed: 2026-04-13T04:45:32.870Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf